COX-2 overexpression has been associated with increased metastatic potential with activation of matrix-degrading metalloproteinase enzymes, and in human endometrial cancer, has also been associated with myometrial invasion and the histological grade of the tumor [27]. The gene discussed is PTGS2; the disease is endometrial cancer.